Lucely Cetina

2.8k total citations
79 papers, 2.1k citations indexed

About

Lucely Cetina is a scholar working on Obstetrics and Gynecology, Epidemiology and Oncology. According to data from OpenAlex, Lucely Cetina has authored 79 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Obstetrics and Gynecology, 27 papers in Epidemiology and 23 papers in Oncology. Recurrent topics in Lucely Cetina's work include Endometrial and Cervical Cancer Treatments (35 papers), Cervical Cancer and HPV Research (23 papers) and Colorectal and Anal Carcinomas (16 papers). Lucely Cetina is often cited by papers focused on Endometrial and Cervical Cancer Treatments (35 papers), Cervical Cancer and HPV Research (23 papers) and Colorectal and Anal Carcinomas (16 papers). Lucely Cetina collaborates with scholars based in Mexico, United States and Spain. Lucely Cetina's co-authors include Alfonso Dueñas‐González, Myrna Candelaria, Jaime Coronel, Horacio Astudillo‐de la Vega, Lucía Taja‐Chayeb, Aurora González‐Fierro, Alma Chávez‐Blanco, David Cantú de León, Catalina Trejo‐Becerril and Claudia Arce and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Annals of Oncology.

In The Last Decade

Lucely Cetina

76 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lucely Cetina Mexico 26 921 592 548 500 360 79 2.1k
David Cantú de León Mexico 28 1.1k 1.2× 353 0.6× 716 1.3× 470 0.9× 401 1.1× 146 2.5k
Jae Hong No South Korea 24 572 0.6× 515 0.9× 365 0.7× 510 1.0× 316 0.9× 126 2.0k
Soo Young Hur South Korea 27 769 0.8× 288 0.5× 384 0.7× 486 1.0× 441 1.2× 97 2.1k
Dong Hoon Suh South Korea 27 669 0.7× 877 1.5× 458 0.8× 551 1.1× 440 1.2× 176 2.5k
Charles M. Quick United States 28 530 0.6× 895 1.5× 469 0.9× 272 0.5× 315 0.9× 92 2.2k
Se Ik Kim South Korea 21 504 0.5× 504 0.9× 220 0.4× 476 1.0× 255 0.7× 126 1.7k
Monica Bacon Canada 12 458 0.5× 389 0.7× 351 0.6× 531 1.1× 286 0.8× 24 1.6k
Yasunobu Kanamori Japan 26 1.0k 1.1× 408 0.7× 245 0.4× 1.1k 2.1× 328 0.9× 72 2.5k
Dimitrios Haidopoulos Greece 20 298 0.3× 534 0.9× 283 0.5× 434 0.9× 442 1.2× 126 1.7k
Manuel Peñalver United States 30 477 0.5× 975 1.6× 446 0.8× 588 1.2× 896 2.5× 95 2.5k

Countries citing papers authored by Lucely Cetina

Since Specialization
Citations

This map shows the geographic impact of Lucely Cetina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucely Cetina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucely Cetina more than expected).

Fields of papers citing papers by Lucely Cetina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucely Cetina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucely Cetina. The network helps show where Lucely Cetina may publish in the future.

Co-authorship network of co-authors of Lucely Cetina

This figure shows the co-authorship network connecting the top 25 collaborators of Lucely Cetina. A scholar is included among the top collaborators of Lucely Cetina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucely Cetina. Lucely Cetina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cetina, Lucely, et al.. (2025). Machine and Deep Learning for the Diagnosis, Prognosis, and Treatment of Cervical Cancer: A Scoping Review. Diagnostics. 15(12). 1543–1543. 2 indexed citations
2.
Cetina, Lucely, et al.. (2024). Sociodemographic characteristics and their association with survival in women with cervical cancer. BMC Cancer. 24(1). 161–161. 5 indexed citations
3.
Castro-Eguiluz, Denisse, et al.. (2023). Quality of life but not cachexia definitions are associated with overall survival in women with cervical cancer: a STROBE-compliant cohort study. Japanese Journal of Clinical Oncology. 54(4). 416–423.
4.
Cetina, Lucely, et al.. (2023). The effect of an anti-inflammatory diet on cervical cancer patients. Clinical Nutrition ESPEN. 58. 504–504. 1 indexed citations
5.
Castro-Eguiluz, Denisse, et al.. (2022). Impact of metabolic syndrome on the risk of endometrial cancer and the role of lifestyle in prevention. Bosnian Journal of Basic Medical Sciences. 22(4). 499–510. 12 indexed citations
6.
Cetina, Lucely, et al.. (2021). Functional foods modulating inflammation and metabolism in chronic diseases: a systematic review. Critical Reviews in Food Science and Nutrition. 62(16). 4371–4392. 44 indexed citations
7.
Castro-Eguiluz, Denisse, et al.. (2021). Validation of the QLQ-CX24 questionnaire for the assessment of quality of life in Mexican women with cervical cancer. International Journal of Gynecological Cancer. 31(9). 1228–1235. 2 indexed citations
8.
Villalobos-Valencia, Ricardo, et al.. (2021). ADXS11-001 LM-LLO as specific immunotherapy in cervical cancer. Human Vaccines & Immunotherapeutics. 17(8). 2617–2625. 20 indexed citations
9.
Cetina, Lucely, et al.. (2020). Body composition and nutritional status according to clinical stage in patients with locally advanced cervical cancer. European Journal of Clinical Nutrition. 75(5). 852–855. 9 indexed citations
10.
Cetina, Lucely & Denisse Castro-Eguiluz. (2020). Consensus Report on the Prevention, Diagnosis, and Treatment of Cervical Cancer – a Perspective from the Immune System Toward Immunotherapy. Revista de investigaci�n Cl�nica. 72(4). 185–187.
11.
Lino‐Silva, Leonardo S., et al.. (2020). Immunotherapy Treatment Against Cervical Cancer. Revista de investigaci�n Cl�nica. 72(4). 231–238. 2 indexed citations
12.
Castro-Eguiluz, Denisse, et al.. (2019). Deterioration of nutritional status of patients with locally advanced cervical cancer during treatment with concomitant chemoradiotherapy. Journal of Human Nutrition and Dietetics. 32(4). 480–491. 28 indexed citations
13.
Coronel, Jaime, et al.. (2018). Carboplatin and low-dose paclitaxel. An effective regimen in older and comorbid patients with advanced cervical cancer. A phase II study. European Journal of Gynaecological Oncology. 39(6). 997–1001. 2 indexed citations
14.
Castro-Eguiluz, Denisse, et al.. (2018). Effects of Dietary Components During and After Concomitant Chemoradiotherapy, Radiotherapy, or Sequential Chemoradiotherapy to the Abdominopelvic Area. Revista de investigaci�n Cl�nica. 70(3). 126–129. 4 indexed citations
15.
16.
Cetina, Lucely, Aarón González-Enciso, David Cantú de León, et al.. (2013). Brachytherapy versus radical hysterectomy after external beam chemoradiation with gemcitabine plus cisplatin: a randomized, phase III study in IB2–IIB cervical cancer patients. Annals of Oncology. 24(8). 2043–2047. 60 indexed citations
17.
Dueñas‐González, Alfonso, et al.. (2012). Emerging drugs for cervical cancer. Expert Opinion on Emerging Drugs. 17(2). 203–218. 12 indexed citations
18.
Candelaria, Myrna, et al.. (2006). Radiosensitizers in cervical cancer. Cisplatin and beyond. Radiation Oncology. 1(1). 15–15. 82 indexed citations
19.
Chávez‐Blanco, Alma, Víctor M. Pérez-Sánchez, Aurora González‐Fierro, et al.. (2004). HER2 expression in cervical cancer as a potential therapeutic target. BMC Cancer. 4(1). 59–59. 58 indexed citations
20.
Dueñas‐González, Alfonso, Lucely Cetina, Ignacio Mariscal, & Horacio Astudillo‐de la Vega. (2003). Modern management of locally advanced cervical carcinoma. Cancer Treatment Reviews. 29(5). 389–399. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Cantú de León Breakdown of academic impact, for papers by Jae Hong No Breakdown of academic impact, for papers by Soo Young Hur Breakdown of academic impact, for papers by Dong Hoon Suh Breakdown of academic impact, for papers by Charles M. Quick Breakdown of academic impact, for papers by Se Ik Kim Breakdown of academic impact, for papers by Monica Bacon Breakdown of academic impact, for papers by Yasunobu Kanamori Breakdown of academic impact, for papers by Dimitrios Haidopoulos Breakdown of academic impact, for papers by Manuel Peñalver
Rankless by CCL
2026